Biocryst Pharmaceuticals Inc

Mid-Cap Stocks Stocks Under $10 Biotech Stocks Healthcare Stocks

$9.38

+0.08 (+0.86%)

As of Aug 8, 10:08 PM ET ·

Analyst Consensus

Strong Buy

Analysts

High

Coverage

Buy 15 88%

Hold 2 12%

Sell 0 0%

Price Target

Analyst Price Target +604.9% upside

Low Target $46.17

Average Target $66.12

High Target $78.89

Current Price $9.38

Current
$9.38

Target
$66.12

$46.17 $66.12 avg $78.89

Scenario Analysis

Bear Case

$46.17

392.2%

Low target

Base Case

$66.12

+604.9%

Avg target

Bull Case

$78.89

+741.0%

High target

Risk/Reward

1.9x

Balanced

Price in Context

52-Week High

$11.22

-16.4% from high

52-Week Low

$6.00

+56.3% from low

Target vs 52W High

$66.12

+489.3% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	38	82%	$257.58	+4.7%
AMGN Amgen Inc	Hold	43	49%	$190.87	-53.6%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+172.3%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	37	81%	$438.34	-11.6%
REGN Regeneron Pharmaceuticals	Buy	37	70%	$76.80	-90.2%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-55.6%
RVMD Revolution Medicines Inc	Strong Buy	28	93%	$114.11	-44.4%
BIIB Biogen Inc	Buy	43	67%	$91.45	-56.0%